Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Non-Current Deffered Revenue (2016 - 2025)

Healthstream (HSTM) has disclosed Non-Current Deffered Revenue for 12 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 18.79% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 18.79% year-over-year, with the annual reading at $1.3 million for FY2025, 18.79% down from the prior year.
  • Non-Current Deffered Revenue for Q4 2025 was $1.3 million at Healthstream, up from $1.3 million in the prior quarter.
  • The five-year high for Non-Current Deffered Revenue was $2.9 million in Q4 2022, with the low at $990000.0 in Q1 2022.
  • Average Non-Current Deffered Revenue over 5 years is $1.8 million, with a median of $1.6 million recorded in 2021.
  • The sharpest move saw Non-Current Deffered Revenue soared 158.79% in 2023, then tumbled 39.01% in 2024.
  • Over 5 years, Non-Current Deffered Revenue stood at $1.6 million in 2021, then surged by 85.53% to $2.9 million in 2022, then dropped by 26.15% to $2.2 million in 2023, then decreased by 23.7% to $1.7 million in 2024, then decreased by 18.79% to $1.3 million in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $1.3 million, $1.3 million, and $1.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.